PMID- 34555778 OWN - NLM STAT- MEDLINE DCOM- 20220302 LR - 20220302 IS - 1532-3072 (Electronic) IS - 0040-8166 (Linking) VI - 73 DP - 2021 Dec TI - Overexpressed LINC00467 promotes the viability and proliferation yet inhibits apoptosis of gastric cancer cells via raising ITGB3 level. PG - 101644 LID - S0040-8166(21)00160-9 [pii] LID - 10.1016/j.tice.2021.101644 [doi] AB - Long non-coding RNA (lncRNA) LINC00467 plays a proto-oncogenic role in non-small cell lung cancer. However, its effect and modulatory mechanism in gastric cancer (GC) are unknown. Thereby, we elucidated the mechanism of LINC00467 in GC. LINC00467 level in GC tissues was assessed by bioinformatic analysis, and clinicopathological parameters from GC patients were collected. The levels of LINC00467, integrin subunit beta 3 (ITGB3), proliferating cell nuclear antigen (PCNA), cleaved caspase-3 and cleaved poly (ADP-ribose) polymerase 1 (PARP1) in tissue samples or treated GC cells were assessed by quantitative real-time polymerase chain reaction (qRT-PCR), fluorescence in situ hybridization (FISH), or Western blot. The viability, proliferation and apoptosis of GC cells were detected by methyl thiazolyl tetrazolium assay, colony formation assay, and flow cytometry. Levels of LINC00467 and ITGB3 were up-regulated in GC, and highly expressed LINC00467 was positively associated with tumor size, differentiation, N stage, and T stage in GC patients. LINC00467 was enriched in cytoplasm of GC cells, and overexpressed LINC00467 promoted the viability and proliferation as well as levels of ITGB3 and PCNA, while suppressing the apoptosis and levels of cleaved caspase-3 and cleaved PARP1 in GC cells. Besides, the effects of shLINC00467 on inhibiting cell viability, proliferation of GC cells and PCNA level and promoting apoptosis as well as levels of cleaved caspase-3 and cleaved PARP1 were all partially reversed by overexpressed ITGB3. Overexpressed LINC00467 enhanced the viability and proliferation but inhibited apoptosis of GC cells via increasing ITGB3 level. CI - Copyright (c) 2021. Published by Elsevier Ltd. FAU - Xu, Limao AU - Xu L AD - Gastroenterology Department, The 3(rd) Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China. FAU - Liu, Chengmin AU - Liu C AD - Gastroenterology Department, The 3(rd) Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China. FAU - Ye, Zhiyao AU - Ye Z AD - Gastroenterology Department, The 3(rd) Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China. FAU - Wu, Chengfeng AU - Wu C AD - Gastroenterology Department, The 3(rd) Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China. FAU - Ding, Yuhang AU - Ding Y AD - Gastroenterology Department, The 3(rd) Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China. FAU - Huang, Juan AU - Huang J AD - Gastroenterology Department, The 3(rd) Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China. Electronic address: huangjun_hj1@163.com. LA - eng PT - Journal Article DEP - 20210921 PL - Scotland TA - Tissue Cell JT - Tissue & cell JID - 0214745 RN - 0 (Integrin beta3) RN - 0 (Proliferating Cell Nuclear Antigen) RN - 0 (RNA, Long Noncoding) RN - EC 2.4.2.30 (Poly(ADP-ribose) Polymerases) RN - EC 3.4.22.- (Caspase 3) SB - IM MH - Aged MH - Apoptosis/*genetics MH - Caspase 3/metabolism MH - Cell Differentiation/genetics MH - Cell Line, Tumor MH - Cell Proliferation/genetics MH - Cell Survival/genetics MH - Cytoplasm/metabolism MH - Female MH - Gene Expression Regulation, Neoplastic MH - Gene Silencing MH - Humans MH - Integrin beta3/*metabolism MH - Male MH - Middle Aged MH - Neoplasm Staging MH - Poly(ADP-ribose) Polymerases/metabolism MH - Proliferating Cell Nuclear Antigen/metabolism MH - RNA, Long Noncoding/genetics/*metabolism MH - Stomach Neoplasms/*genetics/*pathology MH - Tumor Burden MH - Up-Regulation/genetics OTO - NOTNLM OT - Apoptosis OT - Gastric cancer OT - ITGB3 OT - LINC00467 OT - Proliferation EDAT- 2021/09/24 06:00 MHDA- 2022/03/03 06:00 CRDT- 2021/09/23 20:29 PHST- 2021/04/26 00:00 [received] PHST- 2021/08/24 00:00 [revised] PHST- 2021/09/04 00:00 [accepted] PHST- 2021/09/24 06:00 [pubmed] PHST- 2022/03/03 06:00 [medline] PHST- 2021/09/23 20:29 [entrez] AID - S0040-8166(21)00160-9 [pii] AID - 10.1016/j.tice.2021.101644 [doi] PST - ppublish SO - Tissue Cell. 2021 Dec;73:101644. doi: 10.1016/j.tice.2021.101644. Epub 2021 Sep 21.